Table 2

Univariable and multivariable Cox model for overall mortality after discharge

UnadjustedAdjusted
HR95% CIP valueHR95% CIP value
Gender0.6300.823
 Male1-1-
 Female1.10.75 to 1.601.050.69 to 1.60
Age group0.0150.121
 ≤79 years1-1-
 ≥80 years1.611.10 to 2.361.390.92 to 2.11
LVEF0.2090.470
 ≤40%1-1-
 >40%0.770.51 to 1.160.860.56 to 1.31
Hypertension0.185
 No1-
 Yes0.710.42 to 1.18
Diabetes0.749
 No1-
 Yes1.060.73 to 1.54
Active cancer0.003
 No1-
 Yes2.361.35 to 4.14
Chronic pulmonary disease0.600
 No1-
 Yes0.90.59 to 1.35
Stroke0.801
 No1-
 Yes1.060.67 to 1.69
PAD0.884
 No1-
 Yes1.040.60 to 1.82
Dementia<0.001<0.001
 No1-1-
 Yes2.081.41 to 3.072.431.56 to 3.79
Need for caregiving0.002
 No1-
 Yes1.891.26 to 2.83
AF0.006
 No1-
 Yes1.711.17 to 2.51
Sleep apnoea/hypoventilation syndrome0.064
 No1-
 Yes0.610.36 to 1.03
ACEi0.004
 No1-
 Yes0.580.40 to 0.84
Beta-blocker0.479
 No1-
 Yes0.880.60 to 1.27
MRA0.475
 No1-
 Yes1.190.74 to 1.89
Oral anticoagulant0.763
 No1-
 Yes0.940.63 to 1.41
PCr (discharge)*2.551.68 to 3.89<0.0013.282.05 to 5.25<0.001
PUr (discharge)*2.131.45 to 3.12<0.001
PK+ (discharge)10.69 to 1.400.900
PNa+ (discharge)*0.030.00 to 1.050.054
SBP (admission)10.99 to 1.000.463
PDW (admission)0.890.83 to 0.960.0010.90.83 to 0.970.007
RDW (admission)*
 Q11-<0.0011-<0.001
 Q21.40.78 to 2.540.2611.730.89 to 3.360.106
 Q31.530.84 to 2.780.1611.550.79 to 3.030.207
 Q43.211.87 to 5.51<0.0013.92.13 to 7.12<0.001
Platelet (admission)*1.090.64 to 1.840.752
Htc (admission)0.960.93 to 0.980.002
Hgb (admission)0.870.80 to 0.950.001
  • *Logarithm transformation.

  • ACEi, ACE inhibitor; AF, atrial fibrillation; Hgb, haemoglobin; HR, hazard ratio; Htc, haematocrit; LVEF, left ventricle ejection fraction; MRA, mineralocorticoid receptor antagonist; PAD, peripheral arterial disease; PCr, plasma creatinine; PDW, platelet distribution width; PK+, plasma potassium; PNa+, plasma sodium; PUr, plasma urea; Q, quartile; RDW, red cell distribution width; SBP, systolic blood pressure.